No cases of parkinsonism or Guillain-Barré syndrome were observed across registrational studies.2*‡
Through September 2023, BMS safety reporting analysis notes that out of the 3243 cases seen with ABECMA, there were2-4§:
- 5 cases of parkinsonism
- 0 cases of Guillain-Barré syndrome